Abstract
Oligodeoxynucleotides (ODN) are used largely as either primers, antisense, or triplex-forming units. Phosphodiester ODN (PO-ODN), which are very rapidly degraded by exonucleases, must be protected at their ends. Even so, their life span inside cells is quite short. Phosphorothioate ODN (PS-ODN) are less sensitive to nucleases and are extensively used as antisense. Unfortunately, unlike PO-ODN, they interact with a number of molecules, including proteins, in addition to their specific nucleic acid targets. Their affinity for their target is lower than that of PO-ODN. PS-ODN containing propyne groups on C5 of pyrimidine have been shown to have a higher affinity toward their nucleic acid target. Here, we show that propynylated PO-ODN are more stable and much more efficient than their propyne-free counterparts. They are not efficient when they are used as lipoplexes, but they act as specific antisense on electroporation.
References
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J P LeonettiB Lebleu
Dec 17, 1982·Journal of Immunological Methods·G D JohnsonE J Holborow
Apr 18, 1995·Biochemistry·C MouldsR W Wagner
Jun 1, 1995·Current Opinion in Structural Biology·A De MesmaekerS Wendeborn
Jan 1, 1995·Antisense Research and Development·D G Spiller, D M Tidd
Jun 4, 1993·Science·R W WagnerB C Froehler
Jan 1, 1995·Journal of Virology·K RaviprakashM Carl
Jun 29, 1994·Biochimica Et Biophysica Acta·V V VlassovL A Yakubov
Jul 9, 1993·Journal of Medicinal Chemistry·J F MilliganJ C Martin
Aug 11, 1993·Nucleic Acids Research·T L FisherR W Wagner
Sep 1, 1995·Antiviral Research·O S LundJ E Hansen
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·A M GewirtzP M Glazer
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G LewisR W Wagner
May 1, 1996·Trends in Biotechnology·C A Stein
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·S T Crooke, C F Bennett
Aug 1, 1997·Antisense & Nucleic Acid Drug Development·C PichonA C Roche
Jun 6, 1998·Nucleic Acids Research·E G MarcussonN M Dean
May 21, 1998·Antisense & Nucleic Acid Drug Development·S T Crooke
Sep 1, 1996·Nature Biotechnology·W M FlanaganR W Wagner
Apr 24, 1999·The Biochemical Journal·Y HamelC Hélène
Jun 22, 1999·Nucleic Acids Research·L MeunierA C Roche
Jan 19, 2000·Nucleic Acids Research·Y AubertU Asseline
Jan 25, 2000·Antisense & Nucleic Acid Drug Development·S DheurE T Saison-Behmoaras
May 11, 2000·Antisense & Nucleic Acid Drug Development·F Eckstein
May 12, 2000·Biochimica Et Biophysica Acta·S Agrawal